Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.

Serresi M, Siteur B, Hulsman D, Company C, Schmitt MJ, Lieftink C, Morris B, Cesaroni M, Proost N, Beijersbergen RL, van Lohuizen M, Gargiulo G.

J Exp Med. 2018 Dec 3;215(12):3115-3135. doi: 10.1084/jem.20180801. Epub 2018 Nov 28.

2.

Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.

Corradetti C, Jog NR, Cesaroni M, Madaio M, Caricchio R.

J Immunol. 2018 Jan 15;200(2):512-522. doi: 10.4049/jimmunol.1700770. Epub 2017 Dec 13.

PMID:
29237779
3.

Digital Restriction Enzyme Analysis of Methylation (DREAM).

Jelinek J, Lee JT, Cesaroni M, Madzo J, Liang S, Lu Y, Issa JJ.

Methods Mol Biol. 2018;1708:247-265. doi: 10.1007/978-1-4939-7481-8_13.

PMID:
29224148
4.

Correction: Human mutations in integrator complex subunits link transcriptome integrity to brain development.

Oegema R, Baillat D, Schot R, van Unen LM, Brooks A, Kia SK, Hoogeboom AJM, Xia Z, Li W, Cesaroni M, Lequin MH, van Slegtenhorst M, Dobyns WB, de Coo IFM, van den Berg D, Verheijen FW, Kremer A, van der Spek PJ, Heijsman D, Wagner EJ, Fornerod M, Mancini GMS.

PLoS Genet. 2017 Aug 1;13(8):e1006923. doi: 10.1371/journal.pgen.1006923. eCollection 2017 Aug.

5.

Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivity.

Maazi H, Banie H, Aleman Muench GR, Patel N, Wang B, Sankaranarayanan I, Bhargava V, Sato T, Lewis G, Cesaroni M, Karras J, Das A, Soroosh P, Akbari O.

J Allergy Clin Immunol. 2018 Mar;141(3):893-905.e6. doi: 10.1016/j.jaci.2017.04.043. Epub 2017 Jun 1.

PMID:
28579374
6.

Human mutations in integrator complex subunits link transcriptome integrity to brain development.

Oegema R, Baillat D, Schot R, van Unen LM, Brooks A, Kia SK, Hoogeboom AJM, Xia Z, Li W, Cesaroni M, Lequin MH, van Slegtenhorst M, Dobyns WB, de Coo IFM, Verheijen FW, Kremer A, van der Spek PJ, Heijsman D, Wagner EJ, Fornerod M, Mancini GMS.

PLoS Genet. 2017 May 25;13(5):e1006809. doi: 10.1371/journal.pgen.1006809. eCollection 2017 May. Erratum in: PLoS Genet. 2017 Aug 1;13(8):e1006923.

7.

A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.

Kelly AD, Kroeger H, Yamazaki J, Taby R, Neumann F, Yu S, Lee JT, Patel B, Li Y, He R, Liang S, Lu Y, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Jelinek J, Issa JP.

Leukemia. 2017 Oct;31(10):2011-2019. doi: 10.1038/leu.2017.12. Epub 2017 Jan 11.

8.

Transcriptional Selectivity of Epigenetic Therapy in Cancer.

Sato T, Cesaroni M, Chung W, Panjarian S, Tran A, Madzo J, Okamoto Y, Zhang H, Chen X, Jelinek J, Issa JJ.

Cancer Res. 2017 Jan 15;77(2):470-481. doi: 10.1158/0008-5472.CAN-16-0834. Epub 2016 Nov 22.

9.

Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.

Shao WH, Shu DH, Zhen Y, Hilliard B, Priest SO, Cesaroni M, Ting JP, Cohen PL.

Arthritis Rheumatol. 2016 Nov;68(11):2697-2707. doi: 10.1002/art.39733.

10.

Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.

Serresi M, Gargiulo G, Proost N, Siteur B, Cesaroni M, Koppens M, Xie H, Sutherland KD, Hulsman D, Citterio E, Orkin S, Berns A, van Lohuizen M.

Cancer Cell. 2016 Jan 11;29(1):17-31. doi: 10.1016/j.ccell.2015.12.006. Erratum in: Cancer Cell. 2016 Feb 8;29(2):241.

11.

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.

Yamazaki J, Taby R, Jelinek J, Raynal NJ, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Issa JP.

J Natl Cancer Inst. 2015 Nov 13;108(2). pii: djv323. doi: 10.1093/jnci/djv323.

12.

G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition.

Laumet G, Garriga J, Chen SR, Zhang Y, Li DP, Smith TM, Dong Y, Jelinek J, Cesaroni M, Issa JP, Pan HL.

Nat Neurosci. 2015 Dec;18(12):1746-55. doi: 10.1038/nn.4165. Epub 2015 Nov 9.

13.

Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.

Tempera I, De Leo A, Kossenkov AV, Cesaroni M, Song H, Dawany N, Showe L, Lu F, Wikramasinghe P, Lieberman PM.

J Virol. 2015 Oct 14;90(1):345-55. doi: 10.1128/JVI.02318-15. Print 2016 Jan 1.

14.

Global Transcriptome Analysis Reveals That Poly(ADP-Ribose) Polymerase 1 Regulates Gene Expression through EZH2.

Martin KA, Cesaroni M, Denny MF, Lupey LN, Tempera I.

Mol Cell Biol. 2015 Dec;35(23):3934-44. doi: 10.1128/MCB.00635-15. Epub 2015 Sep 14.

15.

TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.

Yamazaki J, Jelinek J, Lu Y, Cesaroni M, Madzo J, Neumann F, He R, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Kantarjian HM, Liang S, Estecio MR, Godley LA, Issa JP.

Cancer Res. 2015 Jul 15;75(14):2833-43. doi: 10.1158/0008-5472.CAN-14-0739. Epub 2015 May 13.

16.

Enhancers compete with a long non-coding RNA for regulation of the Kcnq1 domain.

Schultz BM, Gallicio GA, Cesaroni M, Lupey LN, Engel N.

Nucleic Acids Res. 2015 Jan;43(2):745-59. doi: 10.1093/nar/gku1324. Epub 2014 Dec 24.

17.

In vivo shRNA screens in solid tumors.

Gargiulo G, Serresi M, Cesaroni M, Hulsman D, van Lohuizen M.

Nat Protoc. 2014 Dec;9(12):2880-902. doi: 10.1038/nprot.2014.185. Epub 2014 Nov 20.

PMID:
25411954
18.

Integrator regulates transcriptional initiation and pause release following activation.

Gardini A, Baillat D, Cesaroni M, Hu D, Marinis JM, Wagner EJ, Lazar MA, Shilatifard A, Shiekhattar R.

Mol Cell. 2014 Oct 2;56(1):128-139. doi: 10.1016/j.molcel.2014.08.004. Epub 2014 Sep 4.

19.

Validation of methylation biomarkers that distinguish normal colon mucosa of cancer patients from normal colon mucosa of patients without cancer.

Cesaroni M, Powell J, Sapienza C.

Cancer Prev Res (Phila). 2014 Jul;7(7):717-26. doi: 10.1158/1940-6207.CAPR-13-0407. Epub 2014 May 7.

20.

Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation.

Gardini A, Baillat D, Cesaroni M, Shiekhattar R.

EMBO J. 2014 Apr 16;33(8):890-905. doi: 10.1002/embj.201385567. Epub 2014 Mar 3. Erratum in: EMBO J. 2014 Sep 17;33(18):2134.

21.

Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53.

Licciulli S, Avila JL, Hanlon L, Troutman S, Cesaroni M, Kota S, Keith B, Simon MC, Puré E, Radtke F, Capobianco AJ, Kissil JL.

Cancer Res. 2013 Oct 1;73(19):5974-84. doi: 10.1158/0008-5472.CAN-13-1384. Epub 2013 Aug 13.

22.

In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis.

Gargiulo G, Cesaroni M, Serresi M, de Vries N, Hulsman D, Bruggeman SW, Lancini C, van Lohuizen M.

Cancer Cell. 2013 May 13;23(5):660-76. doi: 10.1016/j.ccr.2013.03.030.

23.

Activating RNAs associate with Mediator to enhance chromatin architecture and transcription.

Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA, Shiekhattar R.

Nature. 2013 Feb 28;494(7438):497-501. doi: 10.1038/nature11884. Epub 2013 Feb 17.

24.

Genome-wide mapping of human DNA-replication origins: levels of transcription at ORC1 sites regulate origin selection and replication timing.

Dellino GI, Cittaro D, Piccioni R, Luzi L, Banfi S, Segalla S, Cesaroni M, Mendoza-Maldonado R, Giacca M, Pelicci PG.

Genome Res. 2013 Jan;23(1):1-11. doi: 10.1101/gr.142331.112. Epub 2012 Nov 27.

25.

Requirement for SNAPC1 in transcriptional responsiveness to diverse extracellular signals.

Baillat D, Gardini A, Cesaroni M, Shiekhattar R.

Mol Cell Biol. 2012 Nov;32(22):4642-50. doi: 10.1128/MCB.00906-12. Epub 2012 Sep 10.

26.

NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation.

Gargiulo G, Levy S, Bucci G, Romanenghi M, Fornasari L, Beeson KY, Goldberg SM, Cesaroni M, Ballarini M, Santoro F, Bezman N, Frigè G, Gregory PD, Holmes MC, Strausberg RL, Pelicci PG, Urnov FD, Minucci S.

Dev Cell. 2009 Mar;16(3):466-81. doi: 10.1016/j.devcel.2009.02.002.

27.

AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets.

Gardini A, Cesaroni M, Luzi L, Okumura AJ, Biggs JR, Minardi SP, Venturini E, Zhang DE, Pelicci PG, Alcalay M.

PLoS Genet. 2008 Nov;4(11):e1000275. doi: 10.1371/journal.pgen.1000275. Epub 2008 Nov 28.

28.

Analysis of Myc-induced histone modifications on target chromatin.

Martinato F, Cesaroni M, Amati B, Guccione E.

PLoS One. 2008;3(11):e3650. doi: 10.1371/journal.pone.0003650. Epub 2008 Nov 5.

29.

CARPET: a web-based package for the analysis of ChIP-chip and expression tiling data.

Cesaroni M, Cittaro D, Brozzi A, Pelicci PG, Luzi L.

Bioinformatics. 2008 Dec 15;24(24):2918-20. doi: 10.1093/bioinformatics/btn542. Epub 2008 Oct 21.

PMID:
18945685
30.

Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive.

Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H, Lüscher B, Amati B.

Nature. 2007 Oct 18;449(7164):933-7. Epub 2007 Sep 26.

PMID:
17898714
31.

Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response.

Gorrini C, Squatrito M, Luise C, Syed N, Perna D, Wark L, Martinato F, Sardella D, Verrecchia A, Bennett S, Confalonieri S, Cesaroni M, Marchesi F, Gasco M, Scanziani E, Capra M, Mai S, Nuciforo P, Crook T, Lough J, Amati B.

Nature. 2007 Aug 30;448(7157):1063-7.

PMID:
17728759
32.

RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.

Fagiani E, Giardina G, Luzi L, Cesaroni M, Quarto M, Capra M, Germano G, Bono M, Capillo M, Pelicci P, Lanfrancone L.

Cancer Res. 2007 Apr 1;67(7):3064-73.

33.

Novel human vaccine strategies and the 5th Framework Programme: pushing the envelope.

Tagliabue A, Cesaroni MP, Lewis DJ.

Vaccine. 2003 Jun 1;21 Suppl 2:S121-7.

PMID:
12763695
34.

Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice.

Giudice ED, Ciaramella A, Balestro N, Neumann D, Romano PG, Cesaroni MP, Maurizi G, Ruggiero P, Boraschi D, Bossù P.

Eur Cytokine Netw. 2001 Jul-Sep;12(3):510-7.

35.

Balance between autocrine interleukin-1beta and caspases defines life versus death of polymorphonuclear cells.

Bossù P, del Grosso E, Cesaroni MP, Maurizi G, Balestro N, Stoppacciaro A, del Giudice E, Ruggiero P, Boraschi D.

Eur Cytokine Netw. 2001 Mar;12(1):177-86.

36.

[Radiofrequency percutaneous ablation in prostatic hypertrophy].

Valli PP, Cesaroni M.

Arch Ital Urol Androl. 2000 Dec;72(4):328-31. Italian.

PMID:
11221065
37.

[Hyperhydration with low mineral Rocchetta water after extracorporeal lithotripsy].

Valli PP, Cesaroni M, Mearini L, Rociola W, Cervelli B, Porena M.

Arch Ital Urol Androl. 2000 Apr;72(1):29-31. Italian.

PMID:
10875164
38.

A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts.

Bossù P, Vanoni M, Wanke V, Cesaroni MP, Tropea F, Melillo G, Asti C, Porzio S, Ruggiero P, Di Cioccio V, Maurizi G, Ciabini A, Alberghina L.

Oncogene. 2000 Apr 20;19(17):2147-54.

39.

Proliferative effect of ammodytin L from the venom of Vipera ammodytes on 208F rat fibroblasts in culture.

Rufini S, Cesaroni MP, Balestro N, Luly P.

Biochem J. 1996 Dec 1;320 ( Pt 2):467-72.

40.

[Cystic renal pathology].

Rosi P, Cesaroni M, Bracarda S, Rociola W, Virgili G.

Arch Ital Urol Androl. 1993 Aug;65(4):341-50. Italian.

PMID:
8353538
41.

Use of 4-(6-methylnaphthalen-2-yl)-4-oxobut-2-enoic acid as a reagent for the spectrophotometric and fluorimetric determination of aliphatic thiol drugs.

Cavrini V, Gatti R, Roveri P, Cesaroni MR.

Analyst. 1988 Sep;113(9):1447-52. No abstract available.

PMID:
3239824
42.

[Treatment of benign prostatic hypertrophy using mepartricin at high dosage].

Giurioli A, Rosi P, Parziani S, Cesaroni M, Ghamari MR.

Minerva Urol Nefrol. 1988 Apr-Jun;40(2 Suppl):38-9. Italian. No abstract available.

PMID:
2460947
43.

Müllerian duct cyst. Clinical evaluation and role of ultrasonography and computed tomography in diagnosis.

Rosi P, Bussani F, Vespasiani G, Virgili G, Cesaroni M, Pelliccioli G.

Rays. 1985 Sep-Dec;10(3):77-84. No abstract available.

PMID:
3916547
44.

[Work group, relational perspective, within a public psychotherapy service].

Longhi S, Pucci C, Di Volo F, Marasco P, Bertoncini M, Cesaroni M.

Minerva Psichiatr. 1985 Jul-Sep;26(3):247-52. Italian. No abstract available.

PMID:
4079722
45.

[Synthesis and antibacterial activity of azomethino and aminomethyl derivatives of 2,7-dimethoxyquinolin-3-carboxaldehyde].

Gatti R, Cavrini V, Cesaroni MR, Roveri P, Brigidi P.

Boll Chim Farm. 1985 Feb;124(2):69-74. Italian. No abstract available.

PMID:
4015868
46.

[Current trends in the diagnosis and follow-up of prostatic inflammation].

Porena M, Rosi P, Virgili G, Cesaroni M, Vespasiani G.

Minerva Urol Nefrol. 1985 Jan-Mar;37(1):51-6. Italian. No abstract available.

PMID:
3901337
47.

Syntheses and in vitro antimycotic activities of 1-benzyl-3-(1-imidazolylmethyl)indoles.

Cavrini V, Gatti R, Roveri P, Cesaroni MR, Mazzoni A, Fiorentini C.

Arch Pharm (Weinheim). 1984 Aug;317(8):662-8. No abstract available.

PMID:
6497596
48.

Synthesis and antimicrobial activity of some 2-(2-nitroethenyl)naphthofuran and -benzofuran derivatives.

Gatti R, Chiarini A, Cesaroni MR, Garuti L.

Arch Pharm (Weinheim). 1983 Oct;316(10):849-51. No abstract available.

PMID:
6651492
49.

[Colorimetric analysis of mercaptopropionylglycine in pharmaceutic formulations].

Raggi MA, Cesaroni MR, Di Pietra AM.

Farmaco Prat. 1983 Aug;38(8):312-6. Italian. No abstract available.

PMID:
6617831
50.

[Non-steroidal anti-inflammatory agents. Stereoisomers of homologues of 2-(4-biphenylyl)-3-hydroxypropionic acid. XII].

Burnelli S, Guarnieri A, Varoli L, Cesaroni MR, Scapini G.

Farmaco Sci. 1983 May;38(5):340-51. Italian.

PMID:
6862004

Supplemental Content

Loading ...
Support Center